Financial Results
Q2/2025 Results - Coming soon!
We are pleased to inform you that Fresenius will announce its Q2/2025 results on August 6, 2025.
Ahead of the Q2/2025 results, we are releasing the Fresenius Aide Memoire, which is based on publicly available information.
Please note that our quiet period will commence from July 24 and extend through August 5. We will be back on August 6 with all relevant documents to present our Q2/2025 financial results, business updates and more.
Q2/25 Results (coming soon)
Q1/2025 WebcastDocuments
Q2/25 Aide Memoire (PDF)Selected Key Figures Q1/2025
GROUP REVENUE 1
€ 5631 m
+ 7% 2
Q1/24: €5,283 m
GROUP EBIT 1
€ 654 m
+4% 3
Q1/24: €631 m
NET INCOME 1, 4
€ 416 m
+12% 3
Q1/24: €371 m
EPS 1, 4
€ 0.74
+12% 3
Q1/24: €0.66
1 Before special items
2 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
3 Growth rate at constant currency (cc) and adjusted for Argentina hyperinflation
4 Excluding Fresenius Medical Care
Revenue by business segment
| € in millions | Q1/25 | Q1/24 | Growth at actual rates | Growth at constant rates | Organic growth1 | Acquisitions/Divestitures | % of total revenue |
|---|---|---|---|---|---|---|---|
Fresenius Kabi | 2,146 | 2,051 | 5% | 5% | 6%1 | -1% | 38% |
Fresenius Helios | 3,394 | 3,154 | 8% | 8% | 8% | 0% | 60% |
Total | 5,631 | 5,283 | 7% | 7% | 7% | 0% | 100%2 |
-
1 Organic growth rate adjusted for accounting effects related to Argentina hyperinflation
2 Remaining 2% Corporate/Other revenue
Before special items